The medical devices industry has enjoyed above average revenue growth over the last decade, a time when the overall economy has been declining. However these gains along with the potential changes from the Affordable Care Act have fueled larger players to acquire stagnant and start-up firms to expand their product lines or gain access to emerging technologies. Consolidation continues to sweep the industry, with the announcement of mega-merger after mega-merger (Medtronic to acquire Covidien, Zimmer to acquire Biomet, Beckon Dickinson to acquire CareFusion) the number of MedTech companies has notably decreased by -18.7% since 2010.

Demands for companies to improve quarterly financial performance are contributing to the acceleration of research and development timelines, via either the Continue reading →